Transient ischemic attack medical therapy

Revision as of 00:29, 30 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Transient ischemic attack Microchapters

Home

Main Stroke Page

Ischemic stroke Page

Hemorrhagic Stroke Page

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Transient Ischemic Attack from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

AHA/ASA Guidelines for Stroke

Future or Investigational Therapies

Case Studies

Case #1

Transient ischemic attack medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transient ischemic attack medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transient ischemic attack medical therapy

CDC on Transient ischemic attack medical therapy

Transient ischemic attack medical therapy in the news

Blogs on Transient ischemic attack medical therapy

Directions to Hospitals Treating Transient ischemic attack

Risk calculators and risk factors for Transient ischemic attack medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Overview

Medical therapy for the management of transient ischemic attack includes emergency or early assessment and long term management to prevent future risk of stroke.[1] [1]

Medical Therapy

The approach to medical management of patients with transient ischemic attack may involve the following:[1]
a) Early assessment and emergency management
b) Long term management and follow up

Early assessment and emergency management

  • Rapid transport to the hospital
  • History and examination
  • IV access
  • Fingerstick glucose to rule out hypoglycemia
  • EKG testing to rule out ongoing ischemia
  • Neuroimaging to rule out infarction

Risk assessment and management plan

After initial evaluation of patient, the decision to further manage the patient in the emergency department observation unit, hospital admission or outpatient follow up depends on no of factors which may include

  • ABCD2 scoring(AHA guidelines)
  • Assessment by emergency physician
  • Opinion of neurologist
  • Risk of future stroke or TIA
  • Patient preference
  • Local resources

Guidelines for the hospitalization of patients with TIA

AHA guidelines

  • ABCD2 score of 3
  • ABCD2 score of 0-2 and uncertainity of completion of work up in 2 days in outpatient
  • ABCD2 score of 0-2 and other evidence suggesting patient's transient ischemic attack may be caused by focal ischemia

NSA guidelines

24-48 hours

  • Hospitalization recommended for early t-PA availability in case of recuurent attack or infarction
  • Early risk assessment and management plan

<1 week
Hospitalization in less than a week of TIA may be recommended in following situations:

  • Symptoms >1 hour
  • Known hypercoaguable disorder
  • Symptomatic internal carotid artery stenosis>50
  • Two or more TIAs per week (crescendo TIA)
  • Cardiac source of embolism (atrial fibrillation)
  • California and ABCD2 suggesting admission

Pharmacological therapy

Hypertension

  • Blood pressure control may be considered in patients with evidence of end organ damage or levels above 220/120mmHg
  • Blood pressure autoregulation without medication may be considered in patients with increased levels in patients with TIA to enhance cerebral perfusion[1]

Non cardioembolic TIA

  • Antiplatelet therapy is recommended as first line.[1]
  • Aspirin 50-325mg/day, combination of aspirin and extended release dipyridamole and clopidogrel may be considered first line treatment.
  • Aspirin and clopidogrel may be started within 24 hours of minor stroke or TIA and may be continued for 21 days.

Cardioembolic TIA

  • Anticoagulation may be recommended in patients with known cardiac source of emboli such as atrial fibrillation and acute MI with ventricular thrombus[1]
  • Anticoagulation therapy with warfarin may be recommended with target INR 2-3
  • Aspirin 325mg may be recommended in patients unable to take anticoagulants

Long Term management

Long term management mainly depends on the modification of underlying risk factors:[1]

  • Control of Blood pressure to <140/90mmHg with ACE inhibitors or Angiotensin receptor blockers or both
  • Blood sugar control <126 mg/dl with antidiabetics
  • Treatment of hyperlipidemia with statins
  • Anticoagulant and antiplatelets for underlying cardiac disease.

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL (1999). "AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association". Stroke. 30 (11): 2502–11. PMID 10548693.

Template:WH Template:WS